Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma.
Manasanch EE, Braylan R, Stetler-Stevenson M, Yuan C, Gounden V, Korde N, Tageja N, Bhutani M, Calvo K, Maric I, Roschewski M, Staudt LM, Landgren O. Manasanch EE, et al. Among authors: staudt lm. Leuk Lymphoma. 2014 Jun;55(6):1402-3. doi: 10.3109/10428194.2013.831091. Epub 2013 Dec 2. Leuk Lymphoma. 2014. PMID: 23915224 Free PMC article. No abstract available.
Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation.
Pérez-Galán P, Mora-Jensen H, Weniger MA, Shaffer AL 3rd, Rizzatti EG, Chapman CM, Mo CC, Stennett LS, Rader C, Liu P, Raghavachari N, Stetler-Stevenson M, Yuan C, Pittaluga S, Maric I, Dunleavy KM, Wilson WH, Staudt LM, Wiestner A. Pérez-Galán P, et al. Among authors: staudt lm. Blood. 2011 Jan 13;117(2):542-52. doi: 10.1182/blood-2010-02-269514. Epub 2010 Oct 18. Blood. 2011. PMID: 20956803 Free PMC article. Clinical Trial.
MYD88 L265P somatic mutation in IgM MGUS.
Landgren O, Staudt L. Landgren O, et al. N Engl J Med. 2012 Dec 6;367(23):2255-6; author reply 2256-7. doi: 10.1056/NEJMc1211959. N Engl J Med. 2012. PMID: 23215570 No abstract available.
Burkitt's Lymphoma.
Roschewski M, Staudt LM, Wilson WH. Roschewski M, et al. Among authors: staudt lm. N Engl J Med. 2022 Sep 22;387(12):1111-1122. doi: 10.1056/NEJMra2025746. N Engl J Med. 2022. PMID: 36129999 Review. No abstract available.
BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?
Dunleavy K, Davis RE, Landgren O, Staudt LM, Wilson WH. Dunleavy K, et al. Among authors: staudt lm. Blood. 2007 Jan 15;109(2):843-4; discussion 844-5. doi: 10.1182/blood-2006-07-038000. Blood. 2007. PMID: 17210865 Free article. No abstract available.
A prospective study of mediastinal gray-zone lymphoma.
Wilson WH, Pittaluga S, Nicolae A, Camphausen K, Shovlin M, Steinberg SM, Roschewski M, Staudt LM, Jaffe ES, Dunleavy K. Wilson WH, et al. Among authors: staudt lm. Blood. 2014 Sep 4;124(10):1563-9. doi: 10.1182/blood-2014-03-564906. Epub 2014 Jul 14. Blood. 2014. PMID: 25024303 Free PMC article. Clinical Trial.
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.
Lionakis MS, Dunleavy K, Roschewski M, Widemann BC, Butman JA, Schmitz R, Yang Y, Cole DE, Melani C, Higham CS, Desai JV, Ceribelli M, Chen L, Thomas CJ, Little RF, Gea-Banacloche J, Bhaumik S, Stetler-Stevenson M, Pittaluga S, Jaffe ES, Heiss J, Lucas N, Steinberg SM, Staudt LM, Wilson WH. Lionakis MS, et al. Among authors: staudt lm. Cancer Cell. 2017 Jun 12;31(6):833-843.e5. doi: 10.1016/j.ccell.2017.04.012. Epub 2017 May 25. Cancer Cell. 2017. PMID: 28552327 Free PMC article.
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19.
Roschewski M, Lionakis MS, Sharman JP, Roswarski J, Goy A, Monticelli MA, Roshon M, Wrzesinski SH, Desai JV, Zarakas MA, Collen J, Rose K, Hamdy A, Izumi R, Wright GW, Chung KK, Baselga J, Staudt LM, Wilson WH. Roschewski M, et al. Among authors: staudt lm. Sci Immunol. 2020 Jun 5;5(48):eabd0110. doi: 10.1126/sciimmunol.abd0110. Epub 2020 Jun 5. Sci Immunol. 2020. PMID: 32503877 Free PMC article.
363 results